Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Early Methylene Blue in the Microhemodynamics of Septic Patients: a Feasibility Randomized Controlled Trial

NCT07264543 is registered in ClinicalTrials.gov with Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva as lead sponsor.

NCT NCT07264543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07264543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Early Methylene Blue in the Microhemodynamics of Septic Patients: a Feasibility Randomized Controlled Trial
Lead sponsor
Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva
Phase
Phase 2/3
Overall status
Recruiting
Start date
January 9, 2026
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoperfusion, septic shock